These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9818746)

  • 41. Discovery of inhibitors against mycobacterium branched-chain amino acid aminotransferases through in silico screening and experimental evaluation.
    Pham MT; Tran TTA; Zayabaatar E
    Lett Appl Microbiol; 2022 Oct; 75(4):942-950. PubMed ID: 35687522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of the bradykinin 1 receptor antagonist SSR240612 after oral administration in Mycobacterium tuberculosis-infected mice.
    Rodrigues-Junior VS; Pail PB; Villela AD; Falcão VCA; Dadda AS; Abbadi BL; Pesquero JB; Santos DS; Basso LA; Campos MM
    Tuberculosis (Edinb); 2018 Mar; 109():1-7. PubMed ID: 29559112
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Discovery, Synthesis and Evaluation of a Ketol-Acid Reductoisomerase Inhibitor.
    Bayaraa T; Kurz JL; Patel KM; Hussein WM; Bilyj JK; West NP; Schenk G; McGeary RP; Guddat LW
    Chemistry; 2020 Jul; 26(41):8958-8968. PubMed ID: 32198779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of the Mycobacterium smegmatis and BCG models for the discovery of Mycobacterium tuberculosis inhibitors.
    Altaf M; Miller CH; Bellows DS; O'Toole R
    Tuberculosis (Edinb); 2010 Nov; 90(6):333-7. PubMed ID: 20933470
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
    Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
    Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis.
    Verma RK; Agrawal AK; Singh AK; Mohan M; Gupta A; Gupta P; Gupta UD; Misra A
    Tuberculosis (Edinb); 2013 Jul; 93(4):412-7. PubMed ID: 23562366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-Arylaminouracil Derivatives: New Inhibitors of Mycobacterium tuberculosis.
    Matyugina E; Novikov M; Babkov D; Ozerov A; Chernousova L; Andreevskaya S; Smirnova T; Karpenko I; Chizhov A; Murthu P; Lutz S; Kochetkov S; Seley-Radtke KL; Khandazhinskaya AL
    Chem Biol Drug Des; 2015 Dec; 86(6):1387-96. PubMed ID: 26061192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1229-36. PubMed ID: 18068979
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1.
    Neres J; Hartkoorn RC; Chiarelli LR; Gadupudi R; Pasca MR; Mori G; Venturelli A; Savina S; Makarov V; Kolly GS; Molteni E; Binda C; Dhar N; Ferrari S; Brodin P; Delorme V; Landry V; de Jesus Lopes Ribeiro AL; Farina D; Saxena P; Pojer F; Carta A; Luciani R; Porta A; Zanoni G; De Rossi E; Costi MP; Riccardi G; Cole ST
    ACS Chem Biol; 2015 Mar; 10(3):705-14. PubMed ID: 25427196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine models.
    Gao C; Ye TH; Peng CT; Shi YJ; You XY; Xiong L; Ran K; Zhang LD; Zeng XX; Wang NY; Yu LT; Wei YQ
    Biomed Pharmacother; 2017 Apr; 88():603-609. PubMed ID: 28142116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective efficacy of piperine against Mycobacterium tuberculosis.
    Sharma S; Kalia NP; Suden P; Chauhan PS; Kumar M; Ram AB; Khajuria A; Bani S; Khan IA
    Tuberculosis (Edinb); 2014 Jul; 94(4):389-96. PubMed ID: 24880706
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol.
    Colangeli R; Helb D; Sridharan S; Sun J; Varma-Basil M; Hazbón MH; Harbacheuski R; Megjugorac NJ; Jacobs WR; Holzenburg A; Sacchettini JC; Alland D
    Mol Microbiol; 2005 Mar; 55(6):1829-40. PubMed ID: 15752203
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
    Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
    J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.
    Nguyen PC; Delorme V; Bénarouche A; Guy A; Landry V; Audebert S; Pophillat M; Camoin L; Crauste C; Galano JM; Durand T; Brodin P; Canaan S; Cavalier JF
    Bioorg Chem; 2018 Dec; 81():414-424. PubMed ID: 30212765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
    Li W; Obregón-Henao A; Wallach JB; North EJ; Lee RE; Gonzalez-Juarrero M; Schnappinger D; Jackson M
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5198-207. PubMed ID: 27297488
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
    Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential expression of efflux pump genes of Mycobacterium tuberculosis in response to varied subinhibitory concentrations of antituberculosis agents.
    Garima K; Pathak R; Tandon R; Rathor N; Sinha R; Bose M; Varma-Basil M
    Tuberculosis (Edinb); 2015 Mar; 95(2):155-61. PubMed ID: 25680943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chemical synthesis, in vitro acetohydroxyacid synthase (AHAS) inhibition, herbicidal activity, and computational studies of isatin derivatives.
    Wang J; Tan H; Li Y; Ma Y; Li Z; Guddat LW
    J Agric Food Chem; 2011 Sep; 59(18):9892-900. PubMed ID: 21838297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis.
    Machado D; Pires D; Perdigão J; Couto I; Portugal I; Martins M; Amaral L; Anes E; Viveiros M
    PLoS One; 2016; 11(2):e0149326. PubMed ID: 26919135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.